Published in Amino Acids on February 21, 2010
Preliminary evaluation of (177)Lu-labeled knottin peptides for integrin receptor-targeted radionuclide therapy. Eur J Nucl Med Mol Imaging (2010) 1.75
Cardiovascular molecular imaging: focus on clinical translation. Circulation (2011) 1.24
Affibody-based nanoprobes for HER2-expressing cell and tumor imaging. Biomaterials (2010) 1.11
Affibody modified and radiolabeled gold-iron oxide hetero-nanostructures for tumor PET, optical and MR imaging. Biomaterials (2013) 0.99
68Ga-DOTA-affibody molecule for in vivo assessment of HER2/neu expression with PET. Eur J Nucl Med Mol Imaging (2011) 0.97
PET Imaging of Integrin Positive Tumors Using F Labeled Knottin Peptides. Theranostics (2011) 0.92
PET of EGFR expression with an 18F-labeled affibody molecule. J Nucl Med (2012) 0.89
Near-infrared quantum dots for HER2 localization and imaging of cancer cells. Int J Nanomedicine (2014) 0.87
New strategy for monitoring targeted therapy: molecular imaging. Int J Nanomedicine (2013) 0.85
99mTc-labeled cystine knot peptide targeting integrin αvβ6 for tumor SPECT imaging. Mol Pharm (2014) 0.84
Functional mutation of multiple solvent-exposed loops in the Ecballium elaterium trypsin inhibitor-II cystine knot miniprotein. PLoS One (2011) 0.84
Engineering bispecificity into a single albumin-binding domain. PLoS One (2011) 0.83
Engineering agatoxin, a cystine-knot peptide from spider venom, as a molecular probe for in vivo tumor imaging. PLoS One (2013) 0.82
Designed hydrophilic and charge mutations of the fibronectin domain: towards tailored protein biodistribution. Protein Eng Des Sel (2012) 0.82
Protein and peptide probes for molecular imaging. Amino Acids (2011) 0.77
Desired alteration of protein affinities: competitive selection of protein variants using yeast signal transduction machinery. PLoS One (2014) 0.77
Site-Specific Radioiodination of HER2-Targeting Affibody Molecules using 4-Iodophenethylmaleimide Decreases Renal Uptake of Radioactivity. ChemistryOpen (2015) 0.77
Molecular imaging of hepatocellular carcinoma xenografts with epidermal growth factor receptor targeted affibody probes. Biomed Res Int (2013) 0.77
Engineering of bispecific affinity proteins with high affinity for ERBB2 and adaptable binding to albumin. PLoS One (2014) 0.75
A current perspective on applications of macrocyclic-peptide-based high-affinity ligands. Biopolymers (2016) 0.75
Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev (2003) 11.29
Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer (2002) 7.79
Arming antibodies: prospects and challenges for immunoconjugates. Nat Biotechnol (2005) 5.80
High-affinity binders selected from designed ankyrin repeat protein libraries. Nat Biotechnol (2004) 3.34
Selection and identification of single domain antibody fragments from camel heavy-chain antibodies. FEBS Lett (1997) 3.18
Properties, production, and applications of camelid single-domain antibody fragments. Appl Microbiol Biotechnol (2007) 2.59
Tumor imaging using a picomolar affinity HER2 binding affibody molecule. Cancer Res (2006) 2.46
Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging. Clin Cancer Res (2008) 1.96
Mutagenesis and selection of PDZ domains that bind new protein targets. Nat Biotechnol (1999) 1.69
Small-animal PET imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules. J Nucl Med (2008) 1.63
Directed evolution of high-affinity antibody mimics using mRNA display. Chem Biol (2002) 1.57
Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry. J Nucl Med (2009) 1.54
[18F]FBEM-Z(HER2:342)-Affibody molecule-a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomography. Eur J Nucl Med Mol Imaging (2007) 1.50
Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT. J Nucl Med (2008) 1.45
Facile generation of heat-stable antiviral and antitoxin single domain antibodies from a semisynthetic llama library. Anal Chem (2006) 1.39
Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects. Cancer Res (2009) 1.38
Changes in HER2 expression in breast cancer xenografts after therapy can be quantified using PET and (18)F-labeled affibody molecules. J Nucl Med (2009) 1.33
111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors. J Nucl Med (2006) 1.32
A new generation of protein display scaffolds for molecular recognition. Protein Sci (2006) 1.29
Binding proteins from alternative scaffolds. J Immunol Methods (2004) 1.26
Construction of a large phage-displayed human antibody domain library with a scaffold based on a newly identified highly soluble, stable heavy chain variable domain. J Mol Biol (2008) 1.25
Antagonists to human and mouse vascular endothelial growth factor receptor 2 generated by directed protein evolution in vitro. Chem Biol (2006) 1.24
Biosynthesis and biological screening of a genetically encoded library based on the cyclotide MCoTI-I. Chembiochem (2009) 1.24
On the selection of a tracer for PET imaging of HER2-expressing tumors: direct comparison of a 124I-labeled affibody molecule and trastuzumab in a murine xenograft model. J Nucl Med (2009) 1.23
(99m)Tc-maEEE-Z(HER2:342), an Affibody molecule-based tracer for the detection of HER2 expression in malignant tumors. Bioconjug Chem (2007) 1.22
Engineered cystine knot peptides that bind alphavbeta3, alphavbeta5, and alpha5beta1 integrins with low-nanomolar affinity. Proteins (2009) 1.21
Intracellular kinase inhibitors selected from combinatorial libraries of designed ankyrin repeat proteins. J Biol Chem (2005) 1.17
Directed evolution of a protein: selection of potent neutrophil elastase inhibitors displayed on M13 fusion phage. Proc Natl Acad Sci U S A (1992) 1.17
Evaluation of a (64)Cu-labeled cystine-knot peptide based on agouti-related protein for PET of tumors expressing alphavbeta3 integrin. J Nucl Med (2010) 1.15
In vivo evaluation of cysteine-based chelators for attachment of 99mTc to tumor-targeting Affibody molecules. Bioconjug Chem (2007) 1.13
Engineered cystine-knot peptides that bind alpha(v)beta(3) integrin with antibody-like affinities. J Mol Biol (2008) 1.12
SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression. Mol Imaging Biol (2008) 1.12
64Cu-labeled affibody molecules for imaging of HER2 expressing tumors. Mol Imaging Biol (2009) 1.10
A 2-helix small protein labeled with 68Ga for PET imaging of HER2 expression. J Nucl Med (2009) 1.09
In vitro display technologies reveal novel biopharmaceutics. FASEB J (2006) 1.07
Potent inhibitors of beta-tryptase and human leukocyte elastase based on the MCoTI-II scaffold. J Med Chem (2009) 1.06
Development and preclinical characterisation of 99mTc-labelled Affibody molecules with reduced renal uptake. Eur J Nucl Med Mol Imaging (2008) 1.06
Designing scaffolds of peptides for phage display libraries. J Biosci Bioeng (2005) 1.04
Engineering of a femtomolar affinity binding protein to human serum albumin. Protein Eng Des Sel (2008) 1.04
The Nano-tag, a streptavidin-binding peptide for the purification and detection of recombinant proteins. Protein Expr Purif (2004) 1.03
Evaluation of maleimide derivative of DOTA for site-specific labeling of recombinant affibody molecules. Bioconjug Chem (2007) 1.01
A dual-labeled knottin peptide for PET and near-infrared fluorescence imaging of integrin expression in living subjects. Bioconjug Chem (2010) 1.00
Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors. J Nucl Med (2006) 0.99
An engineered knottin peptide labeled with 18F for PET imaging of integrin expression. Bioconjug Chem (2009) 0.98
Searching sequence space for high-affinity binding peptides using ribosome display. J Mol Biol (2003) 0.97
Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine. J Nucl Med (2009) 0.96
Peptide radiopharmaceuticals for diagnosis and therapy. Eur J Nucl Med (2001) 0.96
Engineered two-helix small proteins for molecular recognition. Chembiochem (2009) 0.93
Biopharmaceutical drug discovery using novel protein scaffolds. Curr Opin Biotechnol (2006) 0.92
Generation of tumour-necrosis-factor-alpha-specific affibody molecules capable of blocking receptor binding in vitro. Biotechnol Appl Biochem (2009) 0.91
Construction of an artificial receptor protein ("anticalin") based on the human apolipoprotein D. Chembiochem (2004) 0.90
Use of phage display to probe the evolution of binding specificity and affinity in integrins. Protein Eng (2003) 0.89
Alternate protein frameworks for molecular recognition. Proc Natl Acad Sci U S A (1995) 0.88
Polypeptides from phage display. A superior source of in vivo imaging agents. Q J Nucl Med (1999) 0.87
Chemical synthesis of triple-labelled three-helix bundle binding proteins for specific fluorescent detection of unlabelled protein. Chembiochem (2005) 0.86
In vitro evolution of the binding specificity of neocarzinostatin, an enediyne-binding chromoprotein. Biochemistry (2003) 0.84
TEM-1 beta-lactamase as a scaffold for protein recognition and assay. Protein Sci (2002) 0.83
Alpha-amylase inhibitors selected from a combinatorial library of a cellulose binding domain scaffold. Proteins (2000) 0.81
Evaluation of epidermal growth factor receptor, carcinoembryonic antigen and Lewis carbohydrate antigens in human colorectal and liver neoplasias. Oncol Rep (2001) 0.78
Evaluation of a maleimido derivative of CHX-A'' DTPA for site-specific labeling of affibody molecules. Bioconjug Chem (2008) 0.77
Carbon nanotubes as photoacoustic molecular imaging agents in living mice. Nat Nanotechnol (2008) 6.41
Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis. Crit Care Med (2007) 3.63
microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide. J Nucl Med (2005) 2.96
microPET-based biodistribution of quantum dots in living mice. J Nucl Med (2007) 2.76
Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice. Small (2009) 2.59
Molecular optical imaging with radioactive probes. PLoS One (2010) 2.36
Targeted microbubbles for imaging tumor angiogenesis: assessment of whole-body biodistribution with dynamic micro-PET in mice. Radiology (2008) 1.88
Radiation-luminescence-excited quantum dots for in vivo multiplexed optical imaging. Small (2010) 1.87
Pulmonary Lophomonas blattarum infection in patients with kidney allograft transplantation. Transpl Int (2006) 1.85
Real-time intravital imaging of RGD-quantum dot binding to luminal endothelium in mouse tumor neovasculature. Nano Lett (2008) 1.85
Preliminary evaluation of (177)Lu-labeled knottin peptides for integrin receptor-targeted radionuclide therapy. Eur J Nucl Med Mol Imaging (2010) 1.75
Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice. Bioconjug Chem (2006) 1.75
Small-animal PET imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules. J Nucl Med (2008) 1.63
Affibody-functionalized gold-silica nanoparticles for Raman molecular imaging of the epidermal growth factor receptor. Small (2011) 1.46
Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles. ACS Nano (2010) 1.46
De novo development of circulating anti-endothelial cell antibodies rather than pre-existing antibodies is associated with post-transplant allograft rejection. Kidney Int (2010) 1.45
Biomarkers of endothelial dysfunction in patients with primary focal segmental glomerulosclerosis. Nephrology (Carlton) (2012) 1.45
Harnessing the power of radionuclides for optical imaging: Cerenkov luminescence imaging. J Nucl Med (2011) 1.43
Intrastriatal transplantation of retinal pigment epithelial cells for the treatment of Parkinson disease: in vivo longitudinal molecular imaging with 18F-P3BZA PET/CT. Radiology (2014) 1.43
Ultrasmall near-infrared non-cadmium quantum dots for in vivo tumor imaging. Small (2010) 1.38
Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects. Cancer Res (2009) 1.38
One-step radiosynthesis of ¹⁸F-AlF-NOTA-RGD₂ for tumor angiogenesis PET imaging. Eur J Nucl Med Mol Imaging (2011) 1.34
In vitro and in vivo uncaging and bioluminescence imaging by using photocaged upconversion nanoparticles. Angew Chem Int Ed Engl (2012) 1.33
Intraoperative imaging of tumors using Cerenkov luminescence endoscopy: a feasibility experimental study. J Nucl Med (2012) 1.30
Near-infrared fluorescent nanoprobes for cancer molecular imaging: status and challenges. Trends Mol Med (2010) 1.28
In vivo near-infrared fluorescence imaging of cancer with nanoparticle-based probes. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 1.26
Synthesis and radioluminescence of PEGylated Eu(3+) -doped nanophosphors as bioimaging probes. Adv Mater (2011) 1.26
Small-animal PET imaging of human epidermal growth factor receptor positive tumor with a 64Cu labeled affibody protein. Bioconjug Chem (2010) 1.24
In vivo tumor-targeted fluorescence imaging using near-infrared non-cadmium quantum dots. Bioconjug Chem (2010) 1.24
Preclinical evaluation of Raman nanoparticle biodistribution for their potential use in clinical endoscopy imaging. Small (2011) 1.21
Semiautomated radiosynthesis and biological evaluation of [18F]FEAU: a novel PET imaging agent for HSV1-tk/sr39tk reporter gene expression. Mol Imaging Biol (2007) 1.21
Reproducibility of 3'-deoxy-3'-(18)F-fluorothymidine microPET studies in tumor xenografts in mice. J Nucl Med (2005) 1.20
A novel method for direct site-specific radiolabeling of peptides using [18F]FDG. Bioconjug Chem (2009) 1.11
Affibody-based nanoprobes for HER2-expressing cell and tumor imaging. Biomaterials (2010) 1.11
Construction and validation of nano gold tripods for molecular imaging of living subjects. J Am Chem Soc (2014) 1.10
Tyrosinase as a multifunctional reporter gene for Photoacoustic/MRI/PET triple modality molecular imaging. Sci Rep (2013) 1.10
64Cu-labeled affibody molecules for imaging of HER2 expressing tumors. Mol Imaging Biol (2009) 1.10
A 2-helix small protein labeled with 68Ga for PET imaging of HER2 expression. J Nucl Med (2009) 1.09
Direct site-specific radiolabeling of an Affibody protein with 4-[18F]fluorobenzaldehyde via oxime chemistry. Mol Imaging Biol (2008) 1.08
HSA coated MnO nanoparticles with prominent MRI contrast for tumor imaging. Chem Commun (Camb) (2010) 1.08
Cy5.5-labeled Affibody molecule for near-infrared fluorescent optical imaging of epidermal growth factor receptor positive tumors. J Biomed Opt (2010) 1.07
A metal-based inhibitor of tumor necrosis factor-α. Angew Chem Int Ed Engl (2012) 1.06
Dynamic visualization of RGD-quantum dot binding to tumor neovasculature and extravasation in multiple living mouse models using intravital microscopy. Small (2010) 1.05
Fluorescent fructose derivatives for imaging breast cancer cells. Bioconjug Chem (2007) 1.05
Endoscopic imaging of Cerenkov luminescence. Biomed Opt Express (2012) 1.05
Impact of a multiple mice holder on quantitation of high-throughput MicroPET imaging with and without Ct attenuation correction. Mol Imaging Biol (2013) 1.05
Optical imaging of reporter gene expression using a positron-emission-tomography probe. J Biomed Opt (2011) 1.04
Ischemic postconditioning-mediated miRNA-21 protects against cardiac ischemia/reperfusion injury via PTEN/Akt pathway. PLoS One (2013) 1.03
Melanin-targeted preclinical PET imaging of melanoma metastasis. J Nucl Med (2009) 1.02
Transferring biomarker into molecular probe: melanin nanoparticle as a naturally active platform for multimodality imaging. J Am Chem Soc (2014) 1.01
A dual-labeled knottin peptide for PET and near-infrared fluorescence imaging of integrin expression in living subjects. Bioconjug Chem (2010) 1.00
Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene. J Nucl Med (2006) 0.99
A novel clinically translatable fluorescent nanoparticle for targeted molecular imaging of tumors in living subjects. Nano Lett (2011) 0.99
Affibody modified and radiolabeled gold-iron oxide hetero-nanostructures for tumor PET, optical and MR imaging. Biomaterials (2013) 0.99
Perylene-diimide-based nanoparticles as highly efficient photoacoustic agents for deep brain tumor imaging in living mice. Adv Mater (2014) 0.98
An engineered knottin peptide labeled with 18F for PET imaging of integrin expression. Bioconjug Chem (2009) 0.98
Development of 18F-labeled picolinamide probes for PET imaging of malignant melanoma. J Med Chem (2013) 0.97
Non-invasive imaging of cysteine cathepsin activity in solid tumors using a 64Cu-labeled activity-based probe. PLoS One (2011) 0.97
Visualizing implanted tumors in mice with magnetic resonance imaging using magnetotactic bacteria. Clin Cancer Res (2009) 0.95
18F-fluorobenzoate-labeled cystine knot peptides for PET imaging of integrin αvβ6. J Nucl Med (2013) 0.94
Strained cyclooctyne as a molecular platform for construction of multimodal imaging probes. Angew Chem Int Ed Engl (2015) 0.93
Reproducibility study of [(18)F]FPP(RGD)2 uptake in murine models of human tumor xenografts. Eur J Nucl Med Mol Imaging (2010) 0.93
PET of malignant melanoma using 18F-labeled metallopeptides. J Nucl Med (2009) 0.93
Engineered two-helix small proteins for molecular recognition. Chembiochem (2009) 0.93
PET imaging of tumor neovascularization in a transgenic mouse model with a novel 64Cu-DOTA-knottin peptide. Cancer Res (2010) 0.92
PET Imaging of Integrin Positive Tumors Using F Labeled Knottin Peptides. Theranostics (2011) 0.92
Near-infrared quantum dots as optical probes for tumor imaging. Curr Top Med Chem (2010) 0.92
Molecular probes for malignant melanoma imaging. Curr Pharm Biotechnol (2010) 0.91
Radiofluorinated rhenium cyclized α-MSH analogues for PET imaging of melanocortin receptor 1. Bioconjug Chem (2010) 0.91
In vivo bioluminescence tumor imaging of RGD peptide-modified adenoviral vector encoding firefly luciferase reporter gene. Mol Imaging Biol (2007) 0.91
Activatable near-infrared fluorescent probe for in vivo imaging of fibroblast activation protein-alpha. Bioconjug Chem (2012) 0.91
Radioluminescent nanophosphors enable multiplexed small-animal imaging. Opt Express (2012) 0.91
Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma. Contrast Media Mol Imaging (2012) 0.90
Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors. Bioconjug Chem (2012) 0.90
A comparative study of radiolabeled bombesin analogs for the PET imaging of prostate cancer. J Nucl Med (2013) 0.89
Structure-based optimization of FDA-approved drug methylene blue as a c-myc G-quadruplex DNA stabilizer. Biochimie (2011) 0.89
PET of EGFR expression with an 18F-labeled affibody molecule. J Nucl Med (2012) 0.89
Novel, cysteine-modified chelation strategy for the incorporation of [M(I)(CO)(3)](+) (M = Re, (99m)Tc) in an α-MSH peptide. Bioconjug Chem (2012) 0.88
Radiolabeled affibody-albumin bioconjugates for HER2-positive cancer targeting. Bioconjug Chem (2011) 0.88
Adipose tissue-derived stem cells display a proangiogenic phenotype on 3D scaffolds. J Biomed Mater Res A (2011) 0.88
First (18)F-labeled ligand for PET imaging of uPAR: in vivo studies in human prostate cancer xenografts. Nucl Med Biol (2013) 0.87
Discovery of a natural product inhibitor targeting protein neddylation by structure-based virtual screening. Biochimie (2012) 0.87
The manipulation of natural killer cells to target tumor sites using magnetic nanoparticles. Biomaterials (2012) 0.87
Theranostics of malignant melanoma with 64CuCl2. J Nucl Med (2014) 0.87
Ferritin enhances SPIO tracking of C6 rat glioma cells by MRI. Mol Imaging Biol (2011) 0.87
Clickable, hydrophilic ligand for fac-[M(I)(CO)3](+) (M = Re/(99m)Tc) applied in an S-functionalized α-MSH peptide. Bioconjug Chem (2014) 0.86
Luminescent detection of DNA-binding proteins. Nucleic Acids Res (2011) 0.86
MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention. Cell Physiol Biochem (2013) 0.86
Optical imaging with her2-targeted affibody molecules can monitor hsp90 treatment response in a breast cancer xenograft mouse model. Clin Cancer Res (2012) 0.86
Evaluation of 89Zr-rituximab tracer by Cerenkov luminescence imaging and correlation with PET in a humanized transgenic mouse model to image NHL. Mol Imaging Biol (2013) 0.85
99mTc-labeled cystine knot peptide targeting integrin αvβ6 for tumor SPECT imaging. Mol Pharm (2014) 0.84
Functional mutation of multiple solvent-exposed loops in the Ecballium elaterium trypsin inhibitor-II cystine knot miniprotein. PLoS One (2011) 0.84
Human serum albumin conjugated biomolecules for cancer molecular imaging. Curr Pharm Des (2012) 0.84
In vivo biodistribution and small animal PET of (64)Cu-labeled antimicrobial peptoids. Bioconjug Chem (2012) 0.84
A novel radiofluorinated agouti-related protein for tumor angiogenesis imaging. Amino Acids (2012) 0.83
A label-free G-quadruplex-based switch-on fluorescence assay for the selective detection of ATP. Analyst (2012) 0.83